Page 113 - 80_01
P. 113

Class	
  I	
  phosphoinositide	
  3-­-kinases	
  in	
  immunity…	
  

	
  
models	
   of	
   arthritis,	
   the	
   collagen-­-induced	
   arthritis	
   (CIA)	
   dependent	
   on	
   T-­-cell	
  
dependent	
   cytokines	
   and	
   B	
   cell	
   help,	
   and	
   in	
   the	
   neutrophil-­-dependent	
   arthritis	
  
induced	
  by	
  anti-­-collagen	
  II	
  monoclonal	
  antibodies	
  (104).	
  Similarly,	
  in	
  a	
  neutrophil-­-
dependent	
  model	
  of	
  arthritis	
  induced	
  by	
  serum	
  from	
  arthritis	
  K/BxN	
  mice,	
  clinical	
  
symptoms	
   were	
   dependent	
   on	
   p110d	
   and	
   p110?,	
   and	
   IC87114	
   inhibited	
  
progression	
   of	
   the	
   disease	
   (105).	
   In	
   the	
   rat	
   model	
   of	
   adjuvant-­-induced	
   arthritis	
  
(AIA),	
   therapeutic	
   oral	
   administration	
   of	
   the	
   wide	
   spectrum	
   phosphatidylinositol	
  
3-­-kinase	
  inhibitor	
  ZSTK474	
  ameliorated	
  clinical	
  signs	
  of	
  the	
  disease	
  and	
  inhibited	
  
the	
   production	
   of	
   the	
   effector	
   cytokines	
   IFN-­-?	
   and	
   IL-­-17	
   by	
   T	
   cells	
   in	
   vitro,	
   or	
   the	
  
proliferation	
   and	
   prostaglandin	
   E2	
   (PGE2)	
   production	
   by	
   fibroblast-­-like	
  
synoviocytes	
  cells	
  (FLS)	
  (106).	
  PI3K?	
  deficiency	
  in	
  a	
  model	
  of	
  arthritis	
  induced	
  by	
  
transgenic	
   expression	
   of	
   human	
   TNF	
   reduced	
   metalloproteinase	
   secretion	
   by	
  
fibroblasts,	
   cartilage	
   damage	
   and	
   clinical	
   score,	
   yet	
   did	
   not	
   affect	
   recruitment	
   of	
  
inflammatory	
   leukocytes	
   (107).	
   The	
   p110?-­-specific	
   inhibitor	
   AS252424	
   also	
  
inhibited	
   invasiveness	
   and	
   matrix	
   metalloproteinase	
   secretion	
   by	
   human	
   synovial	
  
fibroblasts	
   from	
   patients	
   with	
   RA.	
   Intriguingly,	
   in	
   FLS	
   from	
   rheumatoid	
   arthritis	
  
patiens	
   PI3K	
   p110d	
   was	
   specifically	
   induced	
   in	
   FLS	
   from	
   rheumatoid	
   arthritis	
  
patients	
   by	
   pro-­-inflammatory	
   cytokines	
   like	
   tumor	
   necrosis	
   factor	
   (TNF),	
   TNF	
  
signaling	
  as	
  well	
  as	
  platelet-­-derived	
  growth	
  factor	
  (PDGF)-­-dependent	
  synoviocyte	
  
growth	
   were	
   inhibited	
   by	
   PI3K	
   p110d	
   inhibitors	
   CAL-­-101	
   or	
   INK007,	
   but	
   not	
   by	
  
p110a	
  inhibitors	
  like	
  A66	
  (108).	
  

12.b.	
  Systemic	
  Lupus	
  Erythematosus.	
  	
  

        Systemic	
   Lupus	
   Erythematosus	
   (SLE)	
   is	
   an	
   autoimmune,	
   chronic,	
  
inflammatory,	
  multisystemic	
  disease	
  with	
  a	
  particularly	
  high	
  incidence	
  in	
  females.	
  
SLE	
  is	
  due	
  to	
  tissue	
  and	
  cell	
  damage	
  induced	
  by	
  autoantibodies	
  generated	
  by	
  early	
  
expansion	
  of	
  long-­-lived	
  autoreactive	
  T	
  helper	
  memory	
  cells	
  that	
  trigger	
  polyclonal	
  
hyperactivity	
   of	
   B	
   lymphocyte	
   responses	
   and	
   hypergammaglobulinemia;	
  
expansion	
   of	
   autoreactive	
   B	
   cells	
   leads	
   to	
   enhanced	
   levels	
   of	
   antibodies	
   against	
   a	
  
variety	
   of	
   self	
   antigens,	
   particularly	
   nuclear	
   antigens	
   and	
   DNA.	
   Accumulation	
   of	
  
immune	
  complexes	
  in	
  the	
  kidney	
  leads	
  to	
  inflammatory	
  reaction	
  ultimately	
  leading	
  
to	
  glomerulonephritis.	
  	
  

        There	
   are	
   different	
   animal	
   models	
   that	
   spontaneously	
   develop	
   a	
   SLE-­-
syndrome,	
  including	
  the	
  widely	
  used	
  MRL-­-lpr	
  and	
  MRL-­-gld	
  mice	
  with	
  a	
  mutation	
  in	
  
the	
   expression	
   of	
   the	
   apoptosis-­-signaling	
   Fas	
   molecule	
   or	
   its	
   ligand,	
   respectively.	
  
Roquinsan/san	
   mice	
   have	
   a	
   mutation	
   that	
   produce	
   disregulated	
   expression	
   of	
   the	
  
PI3K	
  binding	
  costimulatory	
  molecule	
  ICOS,	
  show	
  progressively	
  enhanced	
  numbers	
  
of	
   Tfh,	
   of	
   germinal	
   centers	
   and	
   autoantibodies,	
   and	
   nephritis	
   (109,110)	
   with	
   a	
  
prime	
  role	
  for	
  Tfh	
  IFN-­-?	
  (111,112).	
  

                                                                                                                            	
  111	
  

	
  
   108   109   110   111   112   113   114   115   116   117   118